跳至主要内容
临床试验/NL-OMON47522
NL-OMON47522招募中3 期

The SUGAR-DIP trial: Oral medication strategy versus insulin for diabetes in pregnancy - SUGAR-DIP trial

Academisch Medisch Centrum0 个研究点目标入组 810 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
810

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • - Aged 18 years or over
  • - Singleton pregnancy
  • - Diagnosis of GDM as per national guidelines
  • - Indication for pharmacological treatment of GDM
  • - Gestational age between 16 and 34 weeks
  • - Ability to understand Dutch or English
  • - Ability to provide written informed consent

排除标准

  • - Known pre-existent type 1 or type 2 diabetes mellitus
  • - Severe medical or psychiatric comorbidities
  • - Serious liver disease or kidney failure, or any other condition with
  • contraindications for the use of either metformin or glibenclamide*
  • - Pregnancy with a fetus affected by major congenital birth defects and/or
  • chromosomal abnormalities
  • * * e.g. hypersensitivity to glibenclamide / metformin or to any of the
  • excipients, hypersensitivity to other sulphonylureas, history of ketoacidosis,
  • impaired adrenal function, severe infection

研究者

相似试验